相关实验视频

Updated: Sep 15, 2025

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Published on: February 3, 2021

发现用于肝细胞癌的新型c-MET抑制剂,使用综合虚拟查方法

Rushan Fei^1,2, Na Lin^3,2, Xin Zhang⁴

¹Department of Colorectal Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79, Qingchun Road, Hangzhou, Zhejiang Province 310003, China.

ACS medicinal chemistry letters

|July 16, 2025

概括

研究人员发现了一种新型化合物 (化合物10),该化合物强烈抑制c-MET,这是肝细胞癌 (HCC) 的关键标. 这一发现为开发具有较少副作用的有效HCC疗法提供了一个有希望的新途径.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
计算化学计算化学

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
目前的HCC疗法由于耐药性和不良影响而面临局限性.
c-MET受体氨酸激酶与HCC进展和预后不佳有关,代表了治疗标.

研究的目的:

确定用于肝细胞癌 (HCC) 治疗的新型c-MET抑制剂.
为潜在的HCC治疗探索独特的结构框架.
为开发针对性治疗HCC提供洞察力.

主要方法:

采用了一个多步骤的虚拟选工作流.
方法包括分子对接,机器学习预测和分子动力学模拟.
候选化合物被评估为c-MET抑制和抗增殖作用.

主要成果:

化合物10显示出强大的c-MET抑制.
化合物10对Hep3B HCC细胞系表现出选择性的抗增殖作用.
分子动力学模拟证实了化合物10与c-MET的稳定结合,揭示了关键相互作用.

结论:

化合物10是开发HCC治疗的有希望的候选者.
鉴定到的化合物显示出在HCK中具有针对性抑制c-MET的潜力.
这项研究为设计用于HCC治疗的新型c-MET抑制剂提供了宝贵的见解.

关键词:

肝细胞癌是肝细胞癌.在MET中,MET是MET.虚拟选是一个虚拟的选.分子动力学分子动力学

更多相关视频

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...